Publications by authors named "Scott Fettner"

Claim this Profile
S
Safety, tolerability, pharmacokinetics, and pharmacodynamics of a TLR7 agonist prodrug RO6870868 in healthy volunteers.
Joseph F Grippo, Ilia Folitar, Sharon Passe, Qiudi Jiang, Ignacio Rodriguez, Scott H Fettner

Clin Transl Sci· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Pharmacokinetic Characterization of Nacubactam, a Novel β-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy Volunteers.
Navita L Mallalieu, Erica Winter, Scott Fettner, Katie Patel, Elke Zwanziger

Antimicrob Agents Chemother· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence of bioequivalence and positive patient user handling of a tocilizumab autoinjector.
Scott Fettner, Christopher Mela, Florian Wildenhahn, Monica Tavanti, Christine Wells

Expert Opin Drug Deliv· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA.
Hisham Abdallah, Joy C Hsu, Peng Lu, Scott Fettner, Xiaoping Zhang

J Clin Pharmacol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of erlotinib on CYP3A activity, evaluated in vitro and by dual probes in patients with cancer.
Hilary Calvert, Chris Twelves, Malcolm Ranson, Ruth Plummer, Scott Fettner

Anticancer Drugs· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of rifampicin, a prototypical CYP3A4 inducer, on erlotinib pharmacokinetics in healthy subjects.
Marta Hamilton, Julie L Wolf, Daniel W Drolet, Scott H Fettner, Ashok K Rakhit

Cancer Chemother Pharmacol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of disease-drug-drug interaction between single-dose tocilizumab and oral contraceptives in women with active rheumatoid arthritis.
Xiaoping Zhang, Lucy Rowell, Scott Fettner, Carol Lau, Denise Teuber

Int J Clin Pharmacol Ther· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of tocilizumab after subcutaneous administration in patients with rheumatoid arthritis.
Xiaoping Zhang, Ya-Chi Chen, Scott Fettner, Lucy Rowell, Tatiana Gott

Int J Clin Pharmacol Ther· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic interaction study of ritonavir-boosted saquinavir in combination with rifabutin in healthy subjects.
Xiaoping Zhang, Scott Fettner, Elke Zwanziger, Lucy Rowell, Miklos Salgo

Antimicrob Agents Chemother· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of food on the pharmacokinetics of erlotinib, an orally active epidermal growth factor receptor tyrosine-kinase inhibitor, in healthy individuals.
Jie Ling, Scott Fettner, Bert L Lum, Myriam Riek, Ashok Rakhit

Anticancer Drugs· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erlotinib in combination with capecitabine and docetaxel in patients with metastatic breast cancer: a dose-escalation study.
Chris Twelves, José M Trigo, Rob Jones, Flavio De Rosa, Ashok Rakhit, Scott Fettner

Eur J Cancer· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP) predicts in vivo metabolic inhibition.
Ashok Rakhit, Michael P Pantze, Scott Fettner, Hannah M Jones, Jean-Eric Charoin

Eur J Clin Pharmacol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b dose escalation study of erlotinib in combination with infusional 5-Fluorouracil, leucovorin, and oxaliplatin in patients with advanced solid tumors.
Axel-R Hanauske, Jim Cassidy, Javier Sastre, Claus Bolling, Robert J Jones, Scott Fettner

Clin Cancer Res· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I evaluation of a 40-kDa branched-chain long-acting pegylated IFN-alpha-2a with and without cytarabine in patients with chronic myelogenous leukemia.
Moshe Talpaz, Ashok Rakhit, Karen Rittweger, Susan O'Brien, Jorge Cortes, Scott Fettner

Clin Cancer Res· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis